Madhav Bansidhar Shriram has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made in reliance upon exemption provided for in regulation 10 of SEBI (SAST) Regulations, 2011
DSFCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.5 pts less than Nifty Microcap 250 and 2.5 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Madhav Bansidhar Shriram, a member of the promoter family, acquired 46,42,640 shares (5.34% of diluted share capital) of DCM Shriram Fine Chemicals Ltd through an inter-family gift from three relatives: Rohan Shriram (33,593 shares), Uday Shriram (9,61,628 shares) and Divya Shriram (36,47,419 shares). The transfers happened on 13 March and 19 March 2026, with the stated rationale being consolidation of holding within the promoter family. As a result, Madhav Bansidhar Shriram's individual stake in the company rose from 4.94% (42,99,224 shares) to 10.28% (89,41,864 shares), crossing the 10% threshold. The acquisition qualified for exemption from making an open offer under Regulation 10(1)(a)(i) of SEBI SAST Regulations, which covers inter-family transfers, and the prior 10(5) disclosure was made on 9 March 2026 within the prescribed timeline.
No cash consideration changed hands and the overall promoter group shareholding in the company remains unchanged — this is a simple internal reallocation among family members. The transaction is price-neutral for outside shareholders and unlikely to affect the stock price.